Accreditation Information

In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Medicine (ACCME)
CEC designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy (ACPE)
This application-based activity is approved for 1.0 contact hour (.10 CEUs) of continuing pharmacy education credit (UAN 0245-0000-17-009-L01-P).

Nursing (ANCC)
This activity is designated for 1.0 contact hour.
Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

Upon completion of a CE request form, statements of credit for physicians and nurses will be issued via email within 30 business days. Pharmacy credit will be reported directly to the National Association of Boards of Pharmacy®(NABP®) CPE Monitor electronic CE tracking system.

Needs Statement

Oral anticoagulants are used for a variety of conditions such as atrial fibrillation, mechanical heart valves, and the prevention and treatment of venous thromboembolism. Although the risk/benefit ratio of anticoagulation therapy in this patient population has been well established, a large percentage of patients who would benefit from therapy do not receive oral anticoagulants. One often cited barrier to anticoagulant use has been bleeding complications and a lack of effective reversal agents to use in the event of bleeding. Strategies in the reversal of anticoagulation are continuously evolving, with the introduction of prothrombin complex concentrates (PCCs) for warfarin reversal and the new and emerging reversal agents for direct oral anticoagulants (DOACs). Healthcare providers across the continuum of care need to be prepared to use these agents as well as provide education to patients and colleagues regarding their availability. The objective of this national Grand Rounds series is to provide up-to-date, evidence-based data regarding anticoagulation reversal in the setting of severe bleeding and emergency procedures, as well as preventative strategies to avoid or decrease bleeding while on anticoagulation therapy. This ACCME/ANCC/ACPE accredited educational initiative will provide physicians, pharmacists, nurses, and other healthcare professionals with the tools needed to properly identify patients in need of anticoagulation reversal and appropriately select treatment strategies to ensure optimal outcomes for each individual patient.


At the conclusion of this application-based activity, participants will be able to:
•Examine risk factors for the development of bleeding while on anticoagulant therapy and outline strategies that can be used to prevent bleeding events.
•Discuss the limitations of traditional reversal agents for the treatment of bleeding from anticoagulant therapy, including the reversal of vitamin K antagonists and direct oral anticoagulants (DOACs).
•Explore the safety and efficacy of new and emerging anticoagulation reversal agents and identify instances in which DOAC reversal would be beneficial, including active bleeding or surgical intervention.
•Develop effective anticoagulation reversal strategies to minimize bleeding complications based on patient specific factors.

Target Audience

Cardiologists, internal medicine physicians, emergency department physicians, surgeons, residents/fellows, physician assistants, nurse practitioners, registered nurses, pharmacists, and other healthcare professionals involved in the management of patients receiving oral anticoagulation therapy.

Faculty Disclosure

All planners, speakers, authors, and reviewers involved with content development for continuing education activities provided by Creative Educational Concepts, Inc. are expected to disclose any real or perceived conflict of interest related to the content of the activity. Detailed disclosures will be included in participant materials or given prior to the start of the activity.